Document is current
Any future updates will be listed below
-
Authors
Cajuso, Tatiana
Sulo, Päivi https://orcid.org/0000-0002-8058-0783
Tanskanen, Tomas
Katainen, Riku
Taira, Aurora
Hänninen, Ulrika A. https://orcid.org/0000-0003-1558-0450
Kondelin, Johanna
Forsström, Linda
Välimäki, Niko
Aavikko, Mervi https://orcid.org/0000-0003-2583-0150
Kaasinen, Eevi
Ristimäki, Ari https://orcid.org/0000-0002-5373-9234
Koskensalo, Selja https://orcid.org/0000-0001-6959-8715
Lepistö, Anna
Renkonen-Sinisalo, Laura
Seppälä, Toni https://orcid.org/0000-0002-4940-3498
Kuopio, Teijo
Böhm, Jan
Mecklin, Jukka-Pekka
Kilpivaara, Outi
Pitkänen, Esa
Palin, Kimmo https://orcid.org/0000-0002-4621-6128
Aaltonen, Lauri A.
- License Information
-
More Information
Article History
Received: 23 July 2018
Accepted: 31 July 2019
First Online: 6 September 2019
Competing interests
: The Authors declare the following competing interests. L.A.A. has received a lecture fee from Roche Oy and Bayer. M.A. has received a non-financial support from Roche Diagnostics Oy in a form of paid travel expenses for the Roche Sequencing Solutions Sample preparations EMEA User Meeting in Heidelberg, Germany. The remaining authors declare no competing interests.
